NO940160L - Eye preparations containing oxicam or oxicam derivatives - Google Patents

Eye preparations containing oxicam or oxicam derivatives

Info

Publication number
NO940160L
NO940160L NO940160A NO940160A NO940160L NO 940160 L NO940160 L NO 940160L NO 940160 A NO940160 A NO 940160A NO 940160 A NO940160 A NO 940160A NO 940160 L NO940160 L NO 940160L
Authority
NO
Norway
Prior art keywords
oxicam
preparations containing
derivatives
compositions
agent
Prior art date
Application number
NO940160A
Other languages
Norwegian (no)
Other versions
NO940160D0 (en
Inventor
Gerard Schwadrohn
Original Assignee
Europhta Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Europhta Lab filed Critical Europhta Lab
Publication of NO940160D0 publication Critical patent/NO940160D0/en
Publication of NO940160L publication Critical patent/NO940160L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Novel pharmaceutical compositions for ophthalmic use, particularly instillable ophthalmic compositions having average viscosity and characterized in that they contain, as the active principle, an anti-flammatory agent which is optionally combined with an antibacterial agent, a gellable acrylic acid polymer and a basic agent to form a fluid aqueous solute with a pH of 7.0-8.0. The compositions are useful for treating inflammatory diseases of the eyeball.
NO940160A 1991-07-18 1994-01-17 Eye preparations containing oxicam or oxicam derivatives NO940160L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9109096A FR2679135B1 (en) 1991-07-18 1991-07-18 NOVEL OPHTHALMIC COMPOSITIONS WITH IMPROVED ADHESIVITY AND METHODS OF PREPARING THE SAME.
PCT/FR1992/000696 WO1993001814A1 (en) 1991-07-18 1992-07-17 Oxicam or oxicam derivatives-containing ophthalmic compositions

Publications (2)

Publication Number Publication Date
NO940160D0 NO940160D0 (en) 1994-01-17
NO940160L true NO940160L (en) 1994-03-04

Family

ID=9415269

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940160A NO940160L (en) 1991-07-18 1994-01-17 Eye preparations containing oxicam or oxicam derivatives

Country Status (10)

Country Link
EP (1) EP0594770B1 (en)
AT (1) ATE147627T1 (en)
AU (1) AU2388392A (en)
DE (1) DE69216831T2 (en)
DK (1) DK0594770T3 (en)
ES (1) ES2099272T3 (en)
FI (1) FI107700B (en)
FR (1) FR2679135B1 (en)
NO (1) NO940160L (en)
WO (1) WO1993001814A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19511322C2 (en) * 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile eye gels containing medium chain triglycerides and process for their preparation
EP1007049A1 (en) * 1997-08-27 2000-06-14 Hexal AG New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
JP4234907B2 (en) * 1998-05-15 2009-03-04 わかもと製薬株式会社 Anti-inflammatory eye drops
AU1548001A (en) * 1999-11-24 2001-06-04 Wakamoto Pharmaceutical Co., Ltd. Ophthalmic aqueous preparation
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (en) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Highly concentrated stable meloxicam solutions for needleless injection
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1649858A1 (en) * 2003-07-10 2006-04-26 Arturo Jimenez Bayardo Method of preparing an aqueous meloxicam solution and aqueous solution thus produced
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
BRPI0720434A2 (en) * 2006-12-22 2014-01-07 Sigma Tau Ind Farmaceuti USEFUL GEL FOR OPHTHALMIC PHARMACEUTICAL RELEASE
CA2777366C (en) 2009-10-12 2023-11-14 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (en) * 1977-11-07 1985-12-11 東興薬品工業株式会社 eye drops
JPS5913714A (en) * 1982-07-13 1984-01-24 Taito Pfizer Kk Antiphlogistic and analgesic agent for external use

Also Published As

Publication number Publication date
WO1993001814A1 (en) 1993-02-04
EP0594770A1 (en) 1994-05-04
FR2679135B1 (en) 1995-05-19
FI107700B (en) 2001-09-28
ES2099272T3 (en) 1997-05-16
FR2679135A1 (en) 1993-01-22
DK0594770T3 (en) 1997-07-21
FI940224A0 (en) 1994-01-17
DE69216831D1 (en) 1997-02-27
ATE147627T1 (en) 1997-02-15
AU2388392A (en) 1993-02-23
NO940160D0 (en) 1994-01-17
FI940224A (en) 1994-03-14
DE69216831T2 (en) 1997-07-31
EP0594770B1 (en) 1997-01-15

Similar Documents

Publication Publication Date Title
NO940160L (en) Eye preparations containing oxicam or oxicam derivatives
DK0495421T3 (en) Use of carrageenans in topical ophthalmic compositions
BE847686A (en) OCULAR INSERTION BODY FOR THE TREATMENT OF EYE DRYCITIS BY AQUEOUS DEFICIENCY,
SE8900586D0 (en) COMPOSITION AND PROCEDURES TO PREVENT ADHESION BETWEEN BODY TISSUE
ES8802091A1 (en) Improved disinfecting and preserving solutions for contact lenses and methods of use.
RU93056633A (en) ANTIALLERGIC COMPOSITION FOR TREATMENT OF EYES OR NOSE
RU94046143A (en) Pharmaceutical composition for glaucoma treatment
BR9914128A (en) Antibiotic compositions for treatment of the eye, ear and nose
ATE68182T1 (en) THIOPHENE SULPHONE AMIDES FOR THE TREATMENT OF GLAUCOMA.
ES2132241T3 (en) OPHTHALMIC COMPOSITIONS AND METHODS FOR CONSERVATION AND USE.
ATE182586T1 (en) PHARMACOLOGICAL USE OF 5-AMINOPHTHHALOYLHYDRAZIDE; THEIR COMPOSITION AND APPLICATION
SE8801710D0 (en) NEW OPHTALMOLOGICAL COMPOSITION OF MATTER
FI940081A (en) Polyacrylic-based compositions for eye inflammation
NO940064L (en) Eye preparation on polyacrylic acid basis
FR2661091B1 (en) USE OF HEXETIDINE OR ITS DERIVATIVES OR SALTS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR OPHTHALMOLOGICAL USE.
ES2060103T3 (en) HYDROPHILIC AMPHOLYTE POLYMERS, THEIR PREPARATION PROCEDURE, AND THEIR USE AS ABSORBENT AGENTS.
SU850075A1 (en) Medicine for treating eye adenoviral affection
RU93015155A (en) MEDICINE FOR THE TREATMENT OF DYSTROPHIC DISEASES AND INJURIES OF THE EYE TISSUES
BG96092A (en) THIENOTHIOPYRAN SULFONAMIDE DERIVATIVES AND THEIR APPLICATION IN OPHTHALMOLOGICAL PREPARATIONS
CA1273296C (en) Soluble collagen composition
FR2442052A1 (en) Human glaucoma treatment with labetalol - which is an amino- and hydroxyalkyl substd. salicylamide